Home
News
Editorial
MD(e)B(unker)
Related Researches
Di Bella's Foundation
1960-1969
1970-1979
1980-1989
1990-1999
2000-2009
2010-2019
2020-2029
Science news
Scientific Documentation
About us...
Biography
Bibliography
The Method
Di Bella's Method!
1998 Trial!
Media
Video Publications
News-Papers
Press
Testimonial
Testimonies
Video Gallery
Congresses
Video Testimonies
TV & C.
Case History
Lung
Lymphomas
Non-Hodgkin Lymphomas
Hodgkin Lymphomas
Mediastinum
Mesothelioma
Myeloma
Pancreas
Scientific Publications
F.A.Q.
Useful Links
User Side
Vademecum
CouponChief - Resources for Cancer Patients
Contact Us
Home page
News
Related Researches
2000-2009
Title
Created Date
25(OH)D3 and 1,25(OH)2D3 serum concentration and breast tissue expression of 1alpha-hydroxylase, 24-hydroxylase and Vitamin D receptor in women with and without breast cancer
25 April 2017
Cholangiocarcinoma cells express somatostatin receptor subtype 2 and respond to octreotide treatment
13 April 2017
Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells
13 April 2017
A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer
13 April 2017
A combination therapy of dexamethasone and somatostatin analog reintroduces objective clinical responses to LHRH analog in androgen ablation-refractory prostate cancer patients
12 April 2017
Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice
11 April 2017
1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells
11 April 2017
Vitamin D receptor is expressed in pancreatic cancer cells and a vitamin D3 analogue decreases cell number
07 April 2017
Melatonin modulates aromatase activity in MCF-7 human breast cancer cells
06 April 2017
Immunohistochemical detection of somatostatin receptor types 1-5 in medullary carcinoma of the thyroid
04 April 2017
Display #
5
10
15
20
25
30
50
100
All
Page 49 of 111
Start
Prev
44
45
46
47
48
49
50
51
52
53
Next
End
Search
Follow us...
Latest
Melatonin and its ubiquitous anticancer effects
Vitamin E deficiency impairs the somatostatinergic receptor-effector system and leads to phosphotyrosine phosphatase overactivation and cell death in the rat hippocampus
Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells
Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis
High-dose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced cancer
The impact of vitamin D on cancer: A mini review
Solution of retinoids in vitamin E in the Di Bella Method biological multitherapy
Somatostatin and Somatostatin Receptors in Tumour Biology
Immunohistochemical expression of somatostatin receptor subtypes in prostate tissue from cystoprostatectomies with incidental prostate cancer
Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies
Androgen Receptor Regulation of Local Growth Hormone in Prostate Cancer Cells
An updated review of mechanistic potentials of melatonin against cancer: pivotal roles in angiogenesis, apoptosis, autophagy, endoplasmic reticulum stress and oxidative stress
Vitamin D Status in Pediatric Oncology Patients in Lebanon: A Comparison With Non-oncology Controls in a Case-Control Study
Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization
Melatonin and cancer: From the promotion of genomic stability to use in cancer treatment
Targeting Melatonin to Mitochondria Mitigates Castration-Resistant Prostate Cancer by Inducing Pyroptosis
Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions
Is Melatonin the "Next Vitamin D"?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements
Most Read
The Di Bella Method (DBM)
About melatonin - 1996
All-trans-retinoic acid and cancer
Biography
Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
Somatostatin in oncology, the overlooked evidences
The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
Bibliography
Complete objective response to biological therapy of plurifocal breast carcinoma
How effective is chemo therapy?
Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
Vademecum
Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
Frequently Asked Questions
Declaration recommends eliminate the use of Impact factor for research evaluation
Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer